The Enterprise Court of Nivelles approves the BioSenic restructuring plan – Bio Tech Winners
Reader Interactions
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Similar Posts
Ajanta Pharma Shares Gain 5% After Semaglutide Deal With Biocon
December 24, 2025December 24, 2025 Shares of Ajanta Pharma Ltd. surged 5% to touch a day’s high of Rs 2,824 on 24th December. This occurred after the company said it had inked an in-licensing agreement with Biocon Ltd. for semaglutide, a GLP-1 receptor agonist. Under…
Global airlines trim 2025 profit forecast over trade tensions and supply woes
Global airlines trim 2025 profit forecast over trade tensions and supply woes Source link
Overnight Stock Market Movements: Key Developments
July 25, 2025July 25, 2025 Sensex and Nifty 50 are likely to open lower on Friday as investors react to mixed overnight global market cues. Asian markets traded in the red, while Wall Street ended on a mixed note, with the Nasdaq and S&P 500 hitting fresh record highs….
As markets Detach from Reality, Focus on Stocks Producing Real Things – Fat Tail Daily
0 By James Cooper, Friday, 12 December 2025 Cheap resource companies producing real things, that’s what James Cooper and Greg Canavan discuss in this latest edition of Mining Memo. Part Two… Continuing from our last discussion, Greg and I will dig further into the opportunities being presented in resource markets. As we detailed in our…
Where Will Enbridge Stock Be in 5 Years?
Enbridge (TSX:ENB) stock is likely a cornerstone investment in many retirement portfolios geared towards passive income. For investors looking to hold the dividend growth stock for the long term, the futuristic question as we look toward 2030 goes beyond ENB stock’s juicy 6.1% dividend yield to focus on the pipelines giant’s strategic pivot. Enbridge is…
